Literature DB >> 10577933

The importance of a family history of breast cancer in predicting the presence of a BRCA mutation.

W D Foulkes, J S Brunet, E Warner, P J Goodwin, W Meschino, S A Narod, P E Goss, G Glendon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10577933      PMCID： PMC1288389          DOI： 10.1086/302675

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  5 in total

1.  The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews.

Authors:  P Hartge; J P Struewing; S Wacholder; L C Brody; M A Tucker
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

2.  Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women.

Authors:  S E Karp; P N Tonin; L R Bégin; J J Martinez; J C Zhang; M N Pollak; W D Foulkes
Journal:  Cancer       Date:  1997-08-01       Impact factor: 6.860

3.  Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.

Authors:  E Warner; W Foulkes; P Goodwin; W Meschino; J Blondal; C Paterson; H Ozcelik; P Goss; D Allingham-Hawkins; N Hamel; L Di Prospero; V Contiga; C Serruya; M Klein; R Moslehi; J Honeyford; A Liede; G Glendon; J S Brunet; S Narod
Journal:  J Natl Cancer Inst       Date:  1999-07-21       Impact factor: 13.506

4.  BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.

Authors:  D Shattuck-Eidens; A Oliphant; M McClure; C McBride; J Gupte; T Rubano; D Pruss; S V Tavtigian; D H Teng; N Adey; M Staebell; K Gumpper; R Lundstrom; M Hulick; M Kelly; J Holmen; B Lingenfelter; S Manley; F Fujimura; M Luce; B Ward; L Cannon-Albright; L Steele; K Offit; A Thomas
Journal:  JAMA       Date:  1997-10-15       Impact factor: 56.272

5.  Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients.

Authors:  F H Fodor; A Weston; I J Bleiweiss; L D McCurdy; M M Walsh; P I Tartter; S T Brower; C M Eng
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025
  5 in total
  3 in total

1.  The effect of disease penetrance, family size, and age of onset on family history with application to setting eligibility criteria for genetic testing.

Authors:  Alexandre Sibert; David E Goldgar
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

2.  A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families.

Authors:  P Vahteristo; H Eerola; A Tamminen; C Blomqvist; H Nevanlinna
Journal:  Br J Cancer       Date:  2001-03-02       Impact factor: 7.640

3.  Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA).

Authors:  Carmel Apicella; Lesley Andrews; Shirley V Hodgson; Sheila A Fisher; Cathryn M Lewis; Ellen Solomon; Katherine Tucker; Michael Friedlander; Agnes Bankier; Melissa C Southey; Deon J Venter; John L Hopper
Journal:  Breast Cancer Res       Date:  2003-08-28       Impact factor: 6.466
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.